VSE Capital Markets

Dr Reddys Laboratories Ltd

NSE : DRREDDYBSE : 500124ISIN CODE : INE089A01023Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE2,910.55 13.60 (0.47%)

PREV CLOSE (₹) 2,896.95

OPEN PRICE (₹) 2,928.70

BUY PRICE2,908.30(×75)

SELL PRICE 2,910.55(×8)

VOLUME 907

TODAY'S RANGE (₹)2,928.702,900.00

52 WK RANGE(₹)2,990.002,065.30

NSE2,909.70 12.20 (0.42%)

PREV CLOSE( ₹ ) 2,897.50

OPEN PRICE (₹) 2,900.00

BUY PRICE 2,909.00(×25)

SELL PRICE2,909.70(×14)

VOLUME 60,044

TODAY'S RANGE(₹) 2,915.802,897.50

52 WK RANGE (₹)2,991.951,872.95

Stock Summary

MARKET CAP (₹ CR)	48,136.11
P/E	19.14
BOOK VALUE (₹)	852.70
DIV (%)	400.00
MARKET LOT	1.00

EPS (TTM)	151.38
PRICE/BOOK	3.40
DIV YIELD.(%)	0.69
FACE VALUE (₹)	5.00
DELIVERABLES (%)	18.37

Background Information

Incorporation Year	1984
Registered Office	8-2-337 Road No 3,Banjara Hills Hyderabad,Telangana-500034
Telephone	91-40-49002900,Managing Director
Fax	91-40-49002999
Chairman	K Satish Reddy
Managing Director	G V Prasad
Company Secretary	Sandeep Poddar
Auditor	S R Batliboi & Associates LLP/Ernst & Young LLP
Face Value	5
Market Lot	1
Listing	BSE,MSEI ,New York,NSE,
Registrar	Big Share Services Pvt Ltd 3rd Flr 306 Rightwin,Amrutha Ville,Somajiguda,Hyderabad-500082

MF Holdings

Scheme Name	Hold(%)
Aditya Birla SL Equity Fund	4.04
SBI ETF Nifty 50	0.69
Franklin India Focused Equity Fund	4.47
Franklin India Bluechip Fund	4.65
Nippon India Pharma Fund	7.48

News & Announcements

Date	News
06-Dec-2019	Dr Reddys Laboratories launches generic Jadenu® (deferasirox) Film-Coated Tablets in US market
06-Dec-2019	Dr Reddys Laboratories launches Deferasirox Tablets for Oral Suspension
06-Dec-2019	Dr Reddys Laboratories Ltd - Dr. Reddys Laboratories Limited - Press Release
04-Dec-2019	Dr Reddys Laboratories launches Bortezomib for Injection 3.5 mg/vial in US market

Share Holding

Peer Group

Sun Pharmaceuticals Industries Ltd 426.80 ( -0.16)	M.Cap (₹ in Cr) 102571.57
Cipla Ltd 449.80 ( -0.71)	M.Cap (₹ in Cr) 36522.00
Biocon Ltd 284.60 ( -1.69)	M.Cap (₹ in Cr) 34740.00
Piramal Enterprises Ltd 1630.00 ( 1.25)	M.Cap (₹ in Cr) 32018.92
Torrent Pharmaceuticals Ltd 1848.85 ( 1.35)	M.Cap (₹ in Cr) 30870.80

3rd Floor,Fortune Tower,Sayajigunj, Vadodara 390020, Gujarat, India

Telephone: +91 265 2361534

Customer Care Number: +91 265 2361474

Customer Care Timings: Monday to Friday 8:30am to 6:15pm

Email Address: vse@vselindia.com / compliance@vselindia.com

Attention Investors:

"Prevent Unauthorized transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day .......... Issued in the interest of investors
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
KYC is one time exercise while dealing in securities market - once KYC is done through a SEBI registered intermediary (broker , DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

For any complaints pertaining to securities broking please write to compliance@vselindia.com, for DP related to dp@vselindia.com. Please ensure you carefully read the Risk Disclosure Document as prescribed by SEBI.

Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed.